Actively Recruiting
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
Led by Hematology department of the 920th hospital · Updated on 2024-04-22
30
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study was to evaluate the safety and efficacy of a modified allogeneic hematopoietic stem cell transplantation regimen for aplastic anemia.
CONDITIONS
Official Title
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of benign or malignant hematological diseases such as leukemia, lymphoma, thalassemia, or aplastic anemia requiring allogeneic hematopoietic stem cell transplantation
- Age between 3 and 65 years
- Weight between 10 kg and 100 kg
- Eastern Cooperative Oncology Group (ECOG) score 3 or less
- No major organ injury (heart ejection fraction >45%; bilirubin less than twice the upper limit; AST and ALT less than three times the upper limit; serum creatinine less than twice the upper limit)
- No severe infection
- Voluntary participation with signed informed consent
You will not qualify if you...
- Patients with nonhematologic diseases not eligible for transplantation or unwilling to receive transplantation
- Expected survival less than 1 month
- Previous autologous or allogeneic hematopoietic stem cell transplantation
- Pregnancy
- Severe mental or neurological disorders affecting consent or adverse event reporting
- Other conditions deemed inappropriate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Kunming, Yunnan, China, 650000
Actively Recruiting
Research Team
W
wang PI sanbin, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here